Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec 21;9(8):8100-8110.
doi: 10.18632/oncotarget.23568. eCollection 2018 Jan 30.

Meta-analysis of the prognostic value of long non-coding RNA AFAP1-AS1 for cancer patients in China

Rui-Hua Liu #  1 , Ming-Ying Wang #  1   2 , Ling-Yun Chen #  3   2 , Zhi-Jie Yin  1 , Qian-Kun Ji  1 , Yang-Yang Wang  1 , Bao-Zhe Jin  1
Affiliations

Meta-analysis of the prognostic value of long non-coding RNA AFAP1-AS1 for cancer patients in China

Rui-Hua Liu et al. Oncotarget. .

Abstract

LncRNA actin filament-associated protein 1 antisense RNA 1 (AFAP1-AS1) is often dysregulated in cancer. We performed this meta-analysis to clarify the usefulness of AFAP1-AS1 as a prognostic marker in malignant tumors. The PubMed, Medline, OVID, Cochrane Library, and Web of Science databases were searched from inception to Augest 7, 2017. Sixteen studies with a total of 1,386 patients were included in the study. The pooled hazard ratio (HR) suggested high AFAP1-AS1 expression correlated with poor overall survival (OS) (HR = 1.98, 95% confidence interval (CI): 1.71-2.28), disease-free survival (DFS) (HR = 1.54, 95% CI: 1.22-1.95), and progression-free survival (PFS) (HR = 2.17, 95% CI:1.64-2.88) in cancer patients, without obvious heterogeneity. High AFAP1-AS1 expression also correlated with larger tumor size (odds ratio (OR) = 2.04, 95% CI: 1.54-2.72), advanced tumor stage (OR=2.35, 95% CI: 1.70-3.26), poor histological grade (OR =1.39, 95% CI: 1.02-1.90), lymph node metastasis (OR = 2.71, 95% CI: 1.98-3.72) and distant metastasis (OR = 2.96, 95% CI: 2.03-4.32). Thus high AFAP1-AS1 expression is predictive of poor OS, DFS, PFS, lymph node metastasis, distant metastasis, histological grade, larger tumor size and tumor stage, which suggests high AFAP1-AS1 expression may serve as a novel biomarker of poor prognosis in cancer.

Keywords: AFAP1-AS1; LncRNA; metastasis; neoplasms; prognosis.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST The authors declare that there is no conflicts of interests regarding the publication of this paper.

Figures

Figure 1
Figure 1. Flowchart presented the steps of study selection in this meta-analysis
Figure 2
Figure 2. Forest plot showed the association between OS and AFAP1-AS1 expression level in cancer
Figure 3
Figure 3. Forest plot showed the association between DFS, PFS and AFAP1-AS1 expression level in cancer
Figure 4
Figure 4. Forest plot showed the association between tumor size and AFAP1-AS1 expression level in cancer
Figure 5
Figure 5. Forest plot showed the correlation between tumor stage and AFAP1-AS1 expression level in cancer
Figure 6
Figure 6. Forest plot of studies evaluated the correlation between histological grade and AFAP1-AS1 expression level in cancer
Figure 7
Figure 7. Forest plot of studies evaluated the correlation between lymph node metastasis and AFAP1-AS1 expression level in cancer
Figure 8
Figure 8. Forest plot of studies evaluated the relationship between distant metastasis and AFAP1-AS1 expression level in cancer
Figure 9
Figure 9. Funnel plot analysis of potential publication bias in survival and clinicopathological parameters group
(A) OS, (B) DPF + PFS, (C) tumor size, (D) tumor stage, (E) histological grade, (F) lymph node metastasis, (G) distant metastasis.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30. - PubMed
    1. Johnsson P, Lipovich L, Grander D, Morris KV. Evolutionary conservation of long non-coding RNAs; sequence, structure, function. Biochim Biophys Acta. 2014;1840:1063–1071. - PMC - PubMed
    1. Fan YH, Fang H, Ji CX, Xie H, Xiao B, Zhu XG. Long noncoding RNA CCAT2 can predict metastasis and poor prognosis: A meta-analysis. Clin Chim Acta. 2017;466:120–126. - PubMed
    1. Liu T, Zhang X, Gao S, Jing F, Yang Y, Du L, Zheng G, Li P, Li C, Wang C. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer. Oncotarget. 2016;7:85551–85563. http://doi.org/10.18632/oncotarget.13465 - DOI - PMC - PubMed
    1. Cheng N, Li X, Zhao C, Ren S, Chen X, Cai W, Zhao M, Zhang Y, Li J, Wang Q, Zhou C. Microarray expression profile of long non-coding RNAs in EGFR-TKIs resistance of human non-small cell lung cancer. Oncol Rep. 2015;33:833–839. - PubMed